United States

Novo Nordisk A/S (NVO)

NVO on New York Consolidated

2 Dec 2016
Change (% chg)

$0.38 (+1.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Goran Ando

67 2013 Chairman of the Board

Lars Rebien Soerensen

61 2015 President, Chief Executive Officer

Jeppe Christiansen

56 2013 Vice Chairman of the Board

Jesper Brandgaard

52 2000 Chief Financial Officer, Executive Vice President

Maziar Doustdar

45 2015 Executive Vice President, International Operations